ST
ABBV icon

Spinnaker Trust’s AbbVie ABBV Stock Holding History

Spinnaker Trust’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.55M Sell
16,310
-1,026
-6% -$228K 0.2% 86
2025
Q4 		$3.96M Buy
17,336
+704
+4% +$160K 0.21% 86
2025
Q3 		$3.85M Hold
16,632
– – 0.21% 87
2025
Q2 		$3.09M Buy
16,632
+181
+1% +$33.6K 0.19% 94
2025
Q1 		$3.45M Sell
16,451
-333
-2% -$64.7K 0.23% 89
2024
Q4 		$2.98M Buy
16,784
+1,275
+8% +$234K 0.19% 92
2024
Q3 		$3.06M Sell
15,509
-482
-3% -$90K 0.19% 94
2024
Q2 		$2.74M Hold
15,991
– – 0.18% 97
2024
Q1 		$2.91M Sell
15,991
-17
-0.1% -$2.93K 0.19% 99
2023
Q4 		$2.48M Sell
16,008
-300
-2% -$43.7K 0.17% 98
2023
Q3 		$2.43M Buy
16,308
+327
+2% +$48K 0.18% 92
2023
Q2 		$2.15M Buy
15,981
+210
+1% +$30.8K 0.16% 98
2023
Q1 		$2.51M Sell
15,771
-46
-0.3% -$7.03K 0.19% 87
2022
Q4 		$2.56M Sell
15,817
-250
-2% -$38.3K 0.2% 87
2022
Q3 		$2.16M Sell
16,067
-50
-0.3% -$7.17K 0.18% 94
2022
Q2 		$2.47M Sell
16,117
-38
-0.2% -$5.81K 0.19% 97
2022
Q1 		$2.62M Sell
16,155
-352
-2% -$51.1K 0.18% 100
2021
Q4 		$2.23M Buy
16,507
+1,000
+6% +$118K 0.14% 105
2021
Q3 		$1.67M Buy
15,507
+435
+3% +$49.7K 0.12% 108
2021
Q2 		$1.7M Sell
15,072
-19
-0.1% -$2.14K 0.12% 107
2021
Q1 		$1.63M Buy
15,091
+445
+3% +$47.6K 0.12% 102
2020
Q4 		$1.57M Hold
14,646
– – 0.13% 101
2020
Q3 		$1.28M Buy
14,646
+277
+2% +$26.1K 0.11% 102
2020
Q2 		$1.41M Sell
14,369
-161
-1% -$14.2K 0.13% 98
2020
Q1 		$1.11M Sell
14,530
-349
-2% -$29.7K 0.12% 107
2019
Q4 		$1.32M Sell
14,879
-1,903
-11% -$158K 0.12% 114
2019
Q3 		$1.27M Buy
16,782
+1,050
+7% +$72K 0.13% 115
2019
Q2 		$1.14M Buy
15,732
+95
+0.6% +$7.47K 0.11% 114
2019
Q1 		$1.26M Hold
15,637
– – 0.13% 110
2018
Q4 		$1.44M Buy
15,637
+8,645
+124% +$760K 0.16% 99
2018
Q3 		$661K Sell
6,992
-1,050
-13% -$99.6K 0.07% 138
2018
Q2 		$745K Hold
8,042
– – 0.08% 126
2018
Q1 		$761K Buy
8,042
+2,172
+37% +$239K 0.08% 123
2017
Q4 		$567K Buy
5,870
+1,250
+27% +$118K 0.07% 131
2017
Q3 		$410K Sell
4,620
-10
-0.2% -$761 0.05% 149
2017
Q2 		$336K Buy
4,630
+1,374
+42% +$92.4K 0.04% 158
2017
Q1 		$212K Buy
+3,256
New +$205K 0.03% 196
2016
Q1 		– Sell
-3,444
Closed -$204K – 196
2015
Q4 		$204K Sell
3,444
-400
-10% -$23K 0.03% 200
2015
Q3 		$209K Hold
3,844
– – 0.03% 191
2015
Q2 		$258K Buy
+3,844
New +$251K 0.04% 180
2015
Q1 		– Sell
-3,252
Closed -$213K – 195
2014
Q4 		$213K Sell
3,252
-600
-16% -$37.8K 0.03% 187
2014
Q3 		$222K Buy
+3,852
New +$214K 0.04% 178
2014
Q2 		– Sell
-6,141
Closed -$316K – 166
2014
Q1 		$316K Hold
6,141
– – 0.05% 143
2013
Q4 		$324K Buy
6,141
+1,239
+25% +$60.9K 0.05% 136
2013
Q3 		$219K Buy
+4,902
New +$217K 0.04% 147

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Spinnaker Trust's ABBV Position: Q1 2026 in Review

Spinnaker Trust reduced its AbbVie (ABBV) stake by 5.9% in Q1 2026, selling an estimated $228K and leaving 16,310 shares worth $3.55M. The position accounts for 0.2% of the portfolio, ranked #86.

Spinnaker Trust first reported a position in ABBV in Q3 2013 and has held it in 45 quarters since. The position peaked at $3.96M in Q4 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Spinnaker Trust held 16,310 shares of AbbVie worth $3.55M as of Q1 2026.
  • Spinnaker Trust sold 1,026 AbbVie shares in Q1 2026, an estimated $228K.
  • AbbVie made up 0.2% of Spinnaker Trust's portfolio in Q1 2026, its #86 holding.
  • Spinnaker Trust first reported a position in AbbVie in Q3 2013 and has held it in 45 quarters since.
  • Spinnaker Trust's AbbVie position peaked at $3.96M in Q4 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Spinnaker Trust's 13F filing for Q1 2026, filed 23 Apr 2026.